Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Adverum Biotechnologies, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- +3 vs. Q2 2023
- Shares held
- 65.3M
- −397.9K (−0.6%) vs. Q2 2023
- Total value
- $97.9M
- −$6.45M (−6.2%) vs. Q2 2023
- New holders
- 11
- 15 more added
- Sold out
- 8
- 20 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 43 | $0 | 0.00% | −2,359−98.2% | Reduced |
| NBC Securities, Inc. | 500 | $0 | 0.00% | +500 | New |
| BNP Paribas Arbitrage, SA | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 20 | $30 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 200 | $196 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 317 | $476 | 0.00% | +317 | New |
| JPMorgan Chase & Co | 405 | $608 | 0.00% | −1,422−77.8% | Reduced |
| Tower Research Capital LLC (TRC) | 691 | $1.04K | 0.00% | −8,807−92.7% | Reduced |
| UBS Group AG | 800 | $1.20K | 0.00% | −5,490−87.3% | Reduced |
| Parallel Advisors, LLC | 1,000 | $1.50K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,941 | $2.91K | 0.00% | +1,267+188.0% | Added |
| Rhumbline Advisers | 2,937 | $4.41K | 0.00% | 00.0% | Unchanged |
| Nwam LLC | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Ausdal Financial Partners, Inc. | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 10,489 | $15.0K | 0.00% | +430+4.3% | Added |
| American Century Companies Inc | 13,058 | $19.6K | 0.00% | +13,058 | New |
| Lipe & Dalton | 15,000 | $22.0K | 0.01% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 16,000 | $24.0K | 0.00% | +16,000 | New |
| Cubist Systematic Strategies, LLC | 19,884 | $29.8K | 0.00% | −10,874−35.4% | Reduced |
| Captrust Financial Advisors | 20,500 | $30.8K | 0.00% | +20,500 | New |
| HRT Financial LP | 25,098 | $37.0K | 0.00% | +25,098 | New |
| Qube Research & Technologies Ltd | 24,967 | $37.5K | 0.00% | +24,967 | New |
| Jane Street Group, LLC | 33,877 | $50.8K | 0.00% | −12,752−27.3% | Reduced |
| Man Group plc | – | $52.6K | 0.00% | – | New |
| Charles Schwab Investment Management Inc | 36,413 | $54.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 36,657 | $55.0K | 0.01% | +20,325+124.4% | Added |
| Susquehanna International Group, LLP | 42,702 | $64.1K | 0.00% | +19,166+81.4% | Added |
| Mariner, LLC | 50,000 | $75.0K | 0.00% | 00.0% | Unchanged |
| Monaco Asset Management SAM | 59,234 | $88.9K | 0.04% | −175,766−74.8% | Reduced |
| Marquette Asset Management, LLC | 60,120 | $90.2K | 0.02% | −61,273−50.5% | Reduced |
| Bank of New York Mellon Corp | 68,378 | $102.6K | 0.00% | −784−1.1% | Reduced |
| Jefferies Financial Group Inc. | 75,000 | $112.5K | 0.00% | +75,000 | New |
| Advisor Group Holdings, Inc. | 89,367 | $134.1K | 0.00% | +26,217+41.5% | Added |
| Millennium Management LLC | 139,145 | $208.7K | 0.00% | +26,819+23.9% | Added |
| Cantor Fitzgerald, L. P. | 160,060 | $240.1K | 0.01% | −2,778−1.7% | Reduced |
| Northern Trust Corp | 180,351 | $270.5K | 0.00% | −650−0.4% | Reduced |
| Marshall Wace, LLP | 237,331 | $356.0K | 0.00% | +237,331 | New |
| Acuitas Investments, LLC | 291,169 | $436.8K | 0.26% | −322,159−52.5% | Reduced |
| Dimensional Fund Advisors LP | 292,470 | $439.0K | 0.00% | +108,348+58.8% | Added |
| State Street Corp | 330,154 | $495.2K | 0.00% | +48,300+17.1% | Added |
| Worth Venture Partners, LLC | 331,668 | $497.5K | 0.30% | −39,015−10.5% | Reduced |
| Quinn Opportunity Partners LLC | 398,298 | $597.4K | 0.08% | 00.0% | Unchanged |
| Citigroup Inc | 476,692 | $715.0K | 0.00% | +476,692 | New |
| Two Sigma Advisers, LP | 492,700 | $739.0K | 0.00% | +65,500+15.3% | Added |
| Two Sigma Investments, LP | 518,035 | $777.1K | 0.00% | +32,695+6.7% | Added |
| Geode Capital Management, LLC | 864,206 | $1.30M | 0.00% | −22,840−2.6% | Reduced |
| Newtyn Management, LLC | 1,025,000 | $1.54M | 0.38% | +25,000+2.5% | Added |
| AIGH Capital Management LLC | 1,323,985 | $1.99M | 0.94% | −159,572−10.8% | Reduced |
| Renaissance Technologies LLC | 1,329,741 | $2.00M | 0.00% | +113,100+9.3% | Added |
| BlackRock Inc. | 1,401,288 | $2.10M | 0.00% | −2,323−0.2% | Reduced |
| Sonic GP LLC | 2,000,000 | $3.00M | 2.91% | 00.0% | Unchanged |
| BML Capital Management, LLC | 3,915,000 | $5.87M | 5.41% | −1,242,179−24.1% | Reduced |
| Vanguard Group Inc | 4,189,034 | $6.28M | 0.00% | +127,000+3.1% | Added |
| Goldman Sachs Group Inc | 4,556,022 | $6.83M | 0.00% | −5,146−0.1% | Reduced |
| Bank of America Corp | 4,769,186 | $7.15M | 0.00% | −822,604−14.7% | Reduced |
| Versant Venture Management, LLC | 5,068,233 | $7.60M | 4.04% | 00.0% | Unchanged |
| VR Adviser, LLC | 6,573,300 | $9.86M | 1.04% | +2,687,054+69.1% | Added |
| FMR LLC | 6,691,925 | $10.0M | 0.00% | −1,069,367−13.8% | Reduced |
| Morgan Stanley | 6,976,238 | $10.5M | 0.00% | +10,806+0.2% | Added |
| Commodore Capital LP | 10,000,000 | $15.0M | 1.75% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −320,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −122,676−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −84,278−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −21,574−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −19,432−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −13,258−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −18−100.0% | Sold out |